REGN vs TREE
Regeneron Pharmaceuticals Inc (REGN) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the REGN and TREE stock pages for the full models.
Not investment advice.